Access 2.8M+ Filings Sign Up Free
Pharnext Logo

Pharnext | ALPHA - Profile, Filings, Stock Info & Investor Relations Data

Pharnext | ALPHA
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
France
Founded
2007
Pharnext (ALPHA)

Company Profile

Website
Investor Relations

About Pharnext

Our company

Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical needs.

Our drug Candidates

Two drug candidates are currently in clinical development: PXT3003 for the treatment of Charcot-Marie-Tooth disease type 1A and PXT864 for Alzheimer’s disease. Both of our lead assets originated from the Pleotherapy R&D approach.

Employees

44

Market Presence

Worldwide

Headquarters

9 RUE DES FILLES SAINT-THOMAS
75002, PARIS
France

Company Video

Video thumbnail
Click to load video from YouTube

Pharnext (ALPHA)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Pharnext (ALPHA)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Pharnext (ALPHA)
Stock & Investor Information

ISINs

FR0011191287
FR001400BV89
FR001400GUN7
FR001400JXB0
FR001400N1P4

LEI

969500KJGF9ZUYXSMJ27

Stock Exchange Listings

Euronext Growth

Primary Stock Exchange Listing

View Pharnext on main exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology